RAPT Therapeutics Inc (RAPT)

32.17 +1.01  +3.24% NASDAQ Nov 29, 16:00 32.12 -0.05  -0.16% Pre-Market: 20:00 USD
View Full Chart
Price Chart
View All RAPT News


View All Events


Date Type Description
02/15/2022 Earnings Results Q4 2021 Earnings Results
11/10/2021 Earnings Results Q3 2021 Earnings Results
08/11/2021 Earnings Results Q2 2021 Earnings Results
05/28/2021 13:00 EST AGM 2020 Annual General Meeting
05/11/2021 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
  • URL: https://www.rapt.com
  • Investor Relations URL: https://investors.rapt.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Feb. 15, 2022
  • Last Earnings Release: Nov. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.